Clinical Trial Update: Cognitive Rehabilitation in Post-COVID-19 Syndrome [NA]

View source ↗

Summary

A completed University of Missouri-Columbia clinical trial evaluating cognitive rehabilitation for Post-COVID-19 syndrome, with results posted in March 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection
• Post-covid-19 Syndrome

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Post-COVID-19 Syndrome | NA | Status: COMPLETED | Results posted: 2026-03-13